Suchergebnisse - "Honoré, Natasha"

PubPharm (8)

1

Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Honoré, N. | van der Elst, A. | Dietz, A. | +11

CommentOn: Eur J Cancer. 2023 Jul;188:29-38. - PMID 37182343

2

Long-lasting benefit on multimodal treatment combining osimertinib and stereotaxic radiotherapy for metastatic non-small cell lung cancer with the EGFR exon 20 insertion 773-774 HVdelinsLM : a case report

enthalten in: Frontiers in oncology | 2023

von Louvet, A. | Honoré, N. | Dekairelle, A. | +2

3

Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a prospective cohort study

enthalten in: ResearchSquare.com | 2022

von Marcke, C. | Honoré, N. | Elst, A. | +23

4

Liquid Biopsy to Detect Minimal Residual Disease : Methodology and Impact

enthalten in: Cancers | 2021

von Honoré, N. | Galot, R. | van Marcke, C. | +2

5

c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer : From a Case Report to Patient Cohort Analysis

enthalten in: Targeted oncology | 2020

von Van den Bossche, V. | Jadot, G. | Grisay, G. | +7

6

c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis

enthalten in: Targeted oncology | 2020

von Van den Bossche, V. | Jadot, G. | Grisay, G. | +7

7

c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis

enthalten in: Targeted oncology | 2020

von Van den Bossche, V. | Jadot, G. | Grisay, G. | +7

8

c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis

enthalten in: Targeted oncology | 2020

von Van den Bossche, V. | Jadot, G. | Grisay, G. | +7

1
[1]